Javascript must be enabled to continue!
Robert Greene and John of Bordeaux
View through CrossRef
Practically every play of the period 1587–92 that cannot be definitely credited to somebody else has at one time or another been attributed to Robert Greene.1 The canon of Greene's dramatic work has now been fairly well established, however, by conservative modern critics and it includes only those dramas for which there is reasonably sound evidence, external or internal or both, of his authorship. The attribution of yet another play to the formerly all-too-convenient Greene would not ordinarily arouse interest. But the recovery in recent years of John of Bordeaux, a sequel to his Friar Bacon and Friar Bungay (ca. 1589), the appearance in 1936 of an edition of this sequel in the Malone Society Reprints, and the tentative assignment of it to Greene by two such careful scholars as W. L. Renwick and W. W. Greg, its editors—these are developments which deserve more attention than they have yet received.2 There is no contemporary evidence concerning a second part of Friar Bacon,3 and now that a sequel is known to exist, there is no external evidence as to who wrote it. My purpose here is to analyze John of Bordeaux in relation to Greene and his work. This analysis, it may be said at once, supports at every point the assignment of the play to Greene.
Modern Language Association (MLA)
Title: Robert Greene and John of Bordeaux
Description:
Practically every play of the period 1587–92 that cannot be definitely credited to somebody else has at one time or another been attributed to Robert Greene.
1 The canon of Greene's dramatic work has now been fairly well established, however, by conservative modern critics and it includes only those dramas for which there is reasonably sound evidence, external or internal or both, of his authorship.
The attribution of yet another play to the formerly all-too-convenient Greene would not ordinarily arouse interest.
But the recovery in recent years of John of Bordeaux, a sequel to his Friar Bacon and Friar Bungay (ca.
1589), the appearance in 1936 of an edition of this sequel in the Malone Society Reprints, and the tentative assignment of it to Greene by two such careful scholars as W.
L.
Renwick and W.
W.
Greg, its editors—these are developments which deserve more attention than they have yet received.
2 There is no contemporary evidence concerning a second part of Friar Bacon,3 and now that a sequel is known to exist, there is no external evidence as to who wrote it.
My purpose here is to analyze John of Bordeaux in relation to Greene and his work.
This analysis, it may be said at once, supports at every point the assignment of the play to Greene.
Related Results
If I Had Possession over Judgment Day: Augmenting Robert Johnson
If I Had Possession over Judgment Day: Augmenting Robert Johnson
augmentvb [ɔːgˈmɛnt]1. to make or become greater in number, amount, strength, etc.; increase2. Music: to increase (a major or perfect interval) by a semitone (Collins English Dicti...
The Greene Man
The Greene Man
Abstract
Greene liked putting the word ‘man’ in his titles: The Man Within, The Third Man, Our Man in Havana, The Tenth Man, No Man’s Land. In this spirit Marie-F...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Remerciements
Remerciements
Les directrices de ce numéro tiennent à remercier le comité scientifique composé de Cyril Camus (CPGE / CAS, Toulouse-Jean Jaurès), Yves Davo (Université de Bordeaux), Magali Fleur...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Graham Greene's Journeys in Spain and Portugal
Graham Greene's Journeys in Spain and Portugal
Abstract
This book deals with Graham Greene’s travels around Spain and Portugal in the 1970s and 1980s in the company of a Spanish scholar and Catholic priest, Leopo...

